Loading...
NPI 1174925010 · Huntington, WV · Methadone Clinic
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Huntington Treatment Center, LLC is a methadone clinic provider located in Huntington, West Virginia. This profile covers 5 Medicare and 15 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Huntington Treatment Center, LLC |
| Address | 135 4th Ave |
| City | Huntington |
| State | WV |
| ZIP | 25701 |
| Taxonomy | Methadone Clinic |
| NPI Enumerated | September 23, 2014 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $1.2M |
| Medicare | $424.6K |
HUNTINGTON TREATMENT CENTER, LLC is primarily operating as an opioid treatment program focused on methadone-based medication assisted treatment: Medicare top codes are dominated by G2067, G2074, and G2078 which together account for 96.2% of its Medicare revenue, and the code descriptions emphasize weekly bundled methadone treatment, counseling, therapy and take-home methadone supplies. This mix indicates the facility’s core service line is ongoing methadone dispensing combined with behavioral health supports and toxicology testing rather than episodic acute care.
Medicaid billing shows a different mix with E/M visits and toxicology services concentrated in a few codes: the top three Medicaid codes (99213, 99212, 80307) account for 83.9% of Medicaid revenue, implying the provider pairs routine outpatient evaluation/management visits with high-volume drug screening in its Medicaid population. These patterns suggest day-to-day clinic operations that revolve around scheduled visits and frequent monitoring rather than low-frequency procedures.
Revenue concentration is high on both payers but with different dominant services: Medicare revenue totals $424.6K with 96.2% driven by the top three OTP codes (G2067, G2074, G2078), while Medicaid revenue totals $1.2M with 83.9% concentrated in 99213, 99212, and 80307. This indicates Medicare dollars are almost entirely tied to OTP-specific bundled services, whereas Medicaid income is more mixed between primary care-style E/M visits and laboratory testing.
Payer mix is Medicaid-weighted in scale: the provider reports $1.2M in Medicaid revenue versus $424.6K in Medicare revenue, showing Medicaid is the larger revenue source by the figures provided. Operationally, that suggests the clinic’s patient population and reimbursement footprint are more heavily anchored in Medicaid-covered services even though methadone-specific billing drives the Medicare side.
Competitive standing differs by payer and code: for Medicare G2067 revenue the provider ranks #138 of 830 (83rd percentile), which positions it as a typical, mid-to-upper-volume national participant for that OTP bundle, while G2074 ranks #20 of 179 (89th percentile) indicating relatively stronger national placement for the non-drug weekly bundle. On the Medicaid side, 99212 ranks #28 of 536 (95th percentile) showing notably above-typical state volume for that E/M code, and 80305 ranks #16 of 170 (91st percentile) also above typical in-state volume for presumptive drug testing, signaling regional strength in outpatient visits and drug-screening services.
Several codes show routine, unremarkable volume for their peer groups rather than outlier status: Medicare G2078 and G2077 are characterized as typical, unremarkable volume (76th and 85th percentiles respectively), and many Medicaid lab and E/M codes are likewise described as typical for in-state peers—this reinforces that the provider is a steady regional participant rather than an extreme outlier in most service lines.
Tenure in the CMS NPI file is long enough to imply operational stability: the NPI was enumerated on 2014-09-23 (approximately 12 years ago), indicating the clinic has been established for over a decade which aligns with sustained, recurrent billing across both Medicare and Medicaid lines.
Operational implications: high volumes of E/M visits (99213 and 99212 with 9K and 8.7K claims) together with very large counts of presumptive drug tests (80305 with 12K claims and 80307 with 5.4K claims) point to workflow and staffing oriented around frequent patient visits, point-of-care or clinic-based toxicology screening, and ongoing medication dispensing. Payers and network planners should expect this provider to be structured for high-frequency longitudinal care rather than low-volume specialty procedures.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed… | 1,470 | $230 | $334K |
| G2074 | Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services… | 280 | $180 | $50.5K |
| G2078 | Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure | 650 | $40 | $25.2K |
| G2077 | Periodic assessment; assessing periodically by an otp practitioner and includes a review of moud dosing, treatment response, other substance use disorder treatment needs, responses and… | 130 | $110 | $14K |
| G2076 | Intake activities, including initial medical examination that is conducted by an appropriately licensed practitioner and preparation of a care plan, which may be informed by administration of a… | 20 | $130 | $2.1K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 5 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
15 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 8,970 | $50 | $439.5K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 8,710 | $30 | $287.5K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 5,360 | $50 | $241.4K |
| 80305 | The lab analyst performs presumptive drug test(s) by any method that the analyst can read by direct optical observation only, without instrument assistance, to screen for any number of drug classes… | 11,990 | $10 | $131.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 390 | $80 | $32.5K |
| 99211 | An established patient presents for an office or other outpatient visit that may not require the presence of a physician or other qualified healthcare professional. | 600 | $10 | $7.8K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 100 | $50 | $5K |
| 86580 | The lab analyst performs an intradermal skin test on a patient to test for tuberculosis. | 130 | $20 | $2.7K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 70 | $20 | $1.4K |
| 81025 | The lab analyst performs the pregnancy test on a urine specimen using a methodology or kit that the analyst can read visually for a direct readout. | 90 | $20 | $1.4K |
Showing 1–10 of 15
How this provider's Medicaid billing volume and revenue compare to other West Virginia providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. West Virginia median
15 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 36 | 110 | 2,080 | $50 | $537.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 234 | 1,270 | 1,240 | $30 | $245K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 657 | 1,030 | 890 | $50 | $221K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 267 | 330 | 790 | $10 | $64.1K |
| 80074 | The lab analyst performs an acute hepatitis panel; the panel must include tests for hepatitis A IgM antibody, hepatitis B core IgM antibody, hepatitis B surface antigen, and hepatitis C antibody. | 32 | 40 | 180 | $40 | $59.2K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 48 | 110 | 90 | $90 | $46.3K |
| 99212 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,… | 28 | 540 | 320 | $20 | $43.2K |
| 80076 | The lab analyst performs a hepatic function panel test in which he measures the blood levels of total protein, albumin, alkaline phosphatase, bilirubin, both total and direct, and liver enzymes. | 44 | 60 | 300 | $20 | $40.1K |
| 80305 | The lab analyst performs presumptive drug test(s) by any method that the analyst can read by direct optical observation only, without instrument assistance, to screen for any number of drug classes… | 16 | 170 | 800 | $10 | $38.2K |
| 81025 | The lab analyst performs the pregnancy test on a urine specimen using a methodology or kit that the analyst can read visually for a direct readout. | 147 | 200 | 360 | $20 | $33.8K |
Showing 1–10 of 15
Other providers in the same ZIP code as Huntington Treatment Center, LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.